Debiopharm Deploys Genialis Software to Advance AI-Based Biomarker Discovery
Genialis Expressions empowers drug development teams to make confident [...]
When following the science isn’t enough: risk, communication, and the future of biotechnology | TPM podcast #52
Get in touch TPM podcast archive [...]
Frequency of driver mutations across disease stages in Slovenian non-small cell lung cancer patients
This poster presents the first comprehensive analysis of actionable [...]
From platform to portfolio: Using AI to derisk gene therapy and genetic medicine | TPM podcast #51
ESMO AI 2025 poster TPM podcast [...]
A large molecular model (LMM)-based predictor of clinical response to the WEE1 inhibitor Debio 0123 + carboplatin therapy
DNA Damage Response (DDR) dysregulation is a major factor [...]
Real world data and artificial intelligence turn anecdote to evidence | TPM podcast #50
TPM podcast archive Genialis on LinkedIn [...]
The frequency of driver alterations in non-small cell lung cancer patients: Slovenian nationwide observational cohort trial
Next-generation sequencing (NGS) biomarker testing for all newly diagnosed [...]
Genialis and Cleveland Clinic Collaborate to Develop AI-Powered Biomarkers that Improve Pancreatic Cancer Care
The program aims to deliver better guidance for physicians [...]
Genialis™ krasID White Paper
Explore the full story behind the science and innovation [...]
Launching products in healthcare: The most important framework is flexibility | TPM podcast #49
Upcoming events Genialis on LinkedIn [...]
